Medtronic stock triggered by recent performance metrics Medtronic (MDT) is drawing attention after recent share performance, with the stock around $88.44 and returns showing an 11.1% decline over the ...

Medtronic (NYSE:MDT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below ...

If you are wondering whether Medtronic shares are offering good value right now, this article walks through how its current price lines up with different valuation checks. The stock last closed at ...

Medtronic's key catalysts, including Symplicity Spyral, PFA, and Hugo, have promising growth ahead. Click here to read an ...

By Arasu Kannagi Basil March 6 (Reuters) - Medtronic's diabetes business MiniMed shares opened 4.8% below their offer price in Nasdaq debut on Friday, valuing it at $5.35 billion, as heightened market ...

MiniMed (MMED) shares drop 4.8% in Nasdaq debut, opening at $19.05 after raising $560M in IPO. Medtronic (MDT) retains 90% stake in diabetes device spinoff.

Medtronic (NYSE:MDT) has appointed Sean Haag as president of its ear, nose and throat (ENT) business. Haag has also joined ...

Barclays 28th Annual Global Healthcare Conference March 10, 2026 10:30 AM EDTCompany ParticipantsThierry Pieton - Executive VP ...

GALWAY, Ireland and NORTHRIDGE, Calif., March 5, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today ...

Less than a year after announcing the spinout of its diabetes division, Medtronic says it is seeking $784 million in an initial public offering for the MiniMed business. The company plans to sell 28 ...

Is ESTA a good stock to buy? We came across a bullish thesis on Establishment Labs Holdings Inc. on Valueinvestorsclub.com by ...

March 6 (Reuters) - Shares of MiniMed, the diabetes business of medical device maker Medtronic, opened 4.8% below their offer price in their Nasdaq debut on Friday, valuing it at $5.3 billion. The ...